Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

SMAD4 Antikörper

Der Maus Monoklonal anti-SMAD4 Antikörper wird verwendet zum Nachweis von SMAD4 in Proben von Human. Er wurde validiert für IHC (f).
Produktnummer ABIN7126665
-15% Promotion 2026
543,53 €
639,45 €
Sparen Sie 95,92 € (-15 %)
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 9 Werktagen

Kurzübersicht für SMAD4 Antikörper (ABIN7126665)

Target

Alle SMAD4 Antikörper anzeigen
SMAD4 (SMAD Family Member 4 (SMAD4))

Reaktivität

  • 106
  • 56
  • 49
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Wirt

  • 87
  • 19
  • 1
  • 1
Maus

Klonalität

  • 61
  • 47
Monoklonal

Konjugat

  • 63
  • 8
  • 7
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser SMAD4 Antikörper ist unkonjugiert

Applikation

  • 68
  • 43
  • 38
  • 33
  • 23
  • 18
  • 9
  • 7
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Spezifität

    Signaling from the ligand-activated membrane receptor serine/threonine kinases to nuclear targets is mediated by a set of evolutionarily conserved proteins known as DPC4. Upon ligand binding, the receptors of the TGF-i² family phosphorylate SMAD proteins (SMAD1 and SMAD2). These proteins then move into the nucleus, where they activate transcription. To carry out this function, the receptor activated SMAD1 and 2 require association with the product of deleted in pancreatic carcinoma, locus 4 (DPC4), also known as SMAD4. SMAD4/DPC4 is also implicated as a tumor suppressor, since it is inactivated in more than half of pancreatic carcinomas and to a lesser extent in a variety of other cancers. SMAD4 is absent in approximately 80 % of pancreatic adenocarcinoma, but rarely in endometrial, colorectal, ovarian, lung, breast adenocarcinomas, and malignant melanom. SMAD4 is an important marker for confirming a diagnosis of pancreatic adenocarcinoma. Patients with pancreatic adenocarcinomas with SMAD4 protein expression had significantly longer survival than SMAD4 negative patients.

    Kreuzreaktivität (Details)

    Human.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant full-length human STAT6 protein

    Isotyp

    IgG2a
  • Applikationshinweise

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Jurkat or A431 cells. Pancreatic Carcinoma

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    SMAD4 (SMAD Family Member 4 (SMAD4))

    Andere Bezeichnung

    SMAD4

    Hintergrund

    Deleted in Pancreatic Carcinoma 4 (DPC4), JIP, MAD homolog 4 (MADH4), Mothers against decapentaplegic homolog 4 (MADH4), Mothers against DPP homolog 4, MYHRS, SMAD4,SMAD4 (Pancreatic Adenocarcinoma Marker)
    Cellular localisation: Cytoplasmic & Nuclear

    Molekulargewicht

    61kDa

    Gen-ID

    4089, 75862

    UniProt

    Q13485

    Pathways

    Zellzyklus, Chromatin Binding, Autophagie
Sie sind hier:
Chat with us!